共 61 条
Rituximab-related viral infections in lymphoma patients
被引:261
作者:

Aksoy, Sercan
论文数: 0 引用数: 0
h-index: 0
机构:
Hacettepe Univ, Dept Med Oncol, Ankara, Turkey Hacettepe Univ, Dept Med Oncol, Ankara, Turkey

Harputluoglu, Hakan
论文数: 0 引用数: 0
h-index: 0
机构:
Hacettepe Univ, Dept Med Oncol, Ankara, Turkey Hacettepe Univ, Dept Med Oncol, Ankara, Turkey

Kilickap, Saadettin
论文数: 0 引用数: 0
h-index: 0
机构:
Hacettepe Univ, Dept Med Oncol, Ankara, Turkey Hacettepe Univ, Dept Med Oncol, Ankara, Turkey

Dede, Didem Sener
论文数: 0 引用数: 0
h-index: 0
机构:
Hacettepe Univ, Dept Med Oncol, Ankara, Turkey Hacettepe Univ, Dept Med Oncol, Ankara, Turkey

论文数: 引用数:
h-index:
机构:

Altundag, Kadri
论文数: 0 引用数: 0
h-index: 0
机构:
Hacettepe Univ, Dept Med Oncol, Ankara, Turkey Hacettepe Univ, Dept Med Oncol, Ankara, Turkey

Barista, Ibrahim
论文数: 0 引用数: 0
h-index: 0
机构:
Hacettepe Univ, Dept Med Oncol, Ankara, Turkey Hacettepe Univ, Dept Med Oncol, Ankara, Turkey
机构:
[1] Hacettepe Univ, Dept Med Oncol, Ankara, Turkey
关键词:
rituximab;
non-Hodgkin's lymphoma;
viral infections;
D O I:
10.1080/10428190701411441
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Recently, a human/mouse chimeric monoclonal antibody, rituximab, has been successfully used to treat cases of B-cell non-Hodgkin's lymphoma and some autoimmune diseases. However, several viral infections related to rituximab have been reported in the literature, but were not well characterized. To further investigate this topic, relevant English language studies were identified through Medline. There were 64 previously reported cases of serious viral infection after rituximab treatment. The median age of the cases was 61 years (range: 21 - 79). The median time period from the start of rituximab treatment to viral infection diagnosis was 5.0 months (range: 1 - 20). The most frequently experienced viral infections were hepatitis B virus (HBV) (39.1%, n = 25), cytomegalovirus infection (CMV) (23.4%, n = 15), varicella-zoster virus (VZV) ( 9.4%, n = 6), and others (28.1%, n = 18). Of the patients with HBV infections, 13 (52.0%) died due to hepatic failure. Among the 39 cases that had viral infections other than HBV, 13 died due to these specific infections. In this study, about 50% of the rituximab-related HBV infections resulted in death, whereas this was the case in only 33% of the cases with other infections. Close monitoring for viral infection, particularly HBV and CMV, in patients treated with rituximab should be recommended.
引用
收藏
页码:1307 / 1312
页数:6
相关论文
共 61 条
[51]
Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.
[J].
Suzan, F
;
Ammor, M
;
Ribrag, V
.
NEW ENGLAND JOURNAL OF MEDICINE,
2001, 345 (13)
:1000-1000

Suzan, F
论文数: 0 引用数: 0
h-index: 0
机构: Inst Gustave Roussy, F-94805 Villejuif, France

Ammor, M
论文数: 0 引用数: 0
h-index: 0
机构: Inst Gustave Roussy, F-94805 Villejuif, France

Ribrag, V
论文数: 0 引用数: 0
h-index: 0
机构: Inst Gustave Roussy, F-94805 Villejuif, France
[52]
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
[J].
Thomas, DA
;
Faderl, S
;
O'Brien, S
;
Bueso-Ramos, C
;
Cortes, J
;
Garcia-Manero, G
;
Giles, FJ
;
Verstovsek, S
;
Wierda, WG
;
Pierce, SA
;
Shan, JQ
;
Brandt, M
;
Hagemeister, FB
;
Keating, MJ
;
Cabanillas, F
;
Kantarjian, H
.
CANCER,
2006, 106 (07)
:1569-1580

Thomas, DA
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Faderl, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

O'Brien, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Bueso-Ramos, C
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Cortes, J
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Garcia-Manero, G
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Giles, FJ
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Verstovsek, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Wierda, WG
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Pierce, SA
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Shan, JQ
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Brandt, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Hagemeister, FB
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Keating, MJ
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Cabanillas, F
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA

Kantarjian, H
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77230 USA
[53]
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
[J].
Trotti, A
;
Colevas, AD
;
Setser, A
;
Rusch, V
;
Jaques, D
;
Budach, V
;
Langer, C
;
Murphy, B
;
Cumberlin, R
;
Coleman, CN
;
Rubin, P
.
SEMINARS IN RADIATION ONCOLOGY,
2003, 13 (03)
:176-181

Trotti, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Colevas, AD
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Setser, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Rusch, V
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Jaques, D
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Budach, V
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Langer, C
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Murphy, B
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Cumberlin, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Coleman, CN
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA

Rubin, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ S Florida, H Lee Moffitt Canc Ctr, Radiat Oncol Program, Tampa, FL 33612 USA
[54]
Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma
[J].
Tsutsumi, Y
;
Tanaka, J
;
Kawamura, T
;
Miura, T
;
Kanamori, H
;
Obara, S
;
Asaka, M
;
Imamura, M
;
Masauzi, N
.
ANNALS OF HEMATOLOGY,
2004, 83 (01)
:58-60

Tsutsumi, Y
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp 1 10 1, Dept Internal Med, Hakodate, Hokkaido, Japan

Tanaka, J
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp 1 10 1, Dept Internal Med, Hakodate, Hokkaido, Japan

Kawamura, T
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp 1 10 1, Dept Internal Med, Hakodate, Hokkaido, Japan

论文数: 引用数:
h-index:
机构:

Kanamori, H
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp 1 10 1, Dept Internal Med, Hakodate, Hokkaido, Japan

Obara, S
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp 1 10 1, Dept Internal Med, Hakodate, Hokkaido, Japan

论文数: 引用数:
h-index:
机构:

Imamura, M
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp 1 10 1, Dept Internal Med, Hakodate, Hokkaido, Japan

Masauzi, N
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp 1 10 1, Dept Internal Med, Hakodate, Hokkaido, Japan
[55]
Hepatitis B virus reactivation in a case of Non-Hodgkin's lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy
[J].
Tsutsumi, Y
;
Kawamura, T
;
Saitoh, S
;
Yamada, M
;
Obara, S
;
Miura, T
;
Kanamori, H
;
Tanaka, J
;
Asaka, M
;
Imamura, M
;
Masauzi, N
.
LEUKEMIA & LYMPHOMA,
2004, 45 (03)
:627-629

Tsutsumi, Y
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

Kawamura, T
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

Saitoh, S
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

Yamada, M
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

Obara, S
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

论文数: 引用数:
h-index:
机构:

Kanamori, H
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

Tanaka, J
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

Asaka, M
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

Imamura, M
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan

Masauzi, N
论文数: 0 引用数: 0
h-index: 0
机构: Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0410821, Japan
[56]
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkin's lymphoma patient
[J].
Unluturk, Ugur
;
Aksoy, Sercan
;
Yonem, Ozlem
;
Bayraktar, Yusuf
;
Tekuzman, Gulten
.
WORLD JOURNAL OF GASTROENTEROLOGY,
2006, 12 (12)
:1978-1979

论文数: 引用数:
h-index:
机构:

Aksoy, Sercan
论文数: 0 引用数: 0
h-index: 0
机构:
Hacettepe Univ, Inst Oncol, TR-06100 Ankara, Turkey Hacettepe Univ, Inst Oncol, TR-06100 Ankara, Turkey

Yonem, Ozlem
论文数: 0 引用数: 0
h-index: 0
机构: Hacettepe Univ, Inst Oncol, TR-06100 Ankara, Turkey

Bayraktar, Yusuf
论文数: 0 引用数: 0
h-index: 0
机构: Hacettepe Univ, Inst Oncol, TR-06100 Ankara, Turkey

Tekuzman, Gulten
论文数: 0 引用数: 0
h-index: 0
机构: Hacettepe Univ, Inst Oncol, TR-06100 Ankara, Turkey
[57]
Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab
[J].
Vallet, S
;
Tempescul, A
;
Tran, A
;
Legrand-Quillien, MC
;
Narbonne, V
;
Berthou, C
.
ANNALS OF HEMATOLOGY,
2005, 84 (08)
:545-547

Vallet, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ Hosp Morvan, Dept Microbiol, F-29609 Brest, France

Tempescul, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ Hosp Morvan, Dept Microbiol, F-29609 Brest, France

Tran, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ Hosp Morvan, Dept Microbiol, F-29609 Brest, France

Legrand-Quillien, MC
论文数: 0 引用数: 0
h-index: 0
机构: Univ Hosp Morvan, Dept Microbiol, F-29609 Brest, France

Narbonne, V
论文数: 0 引用数: 0
h-index: 0
机构: Univ Hosp Morvan, Dept Microbiol, F-29609 Brest, France

Berthou, C
论文数: 0 引用数: 0
h-index: 0
机构: Univ Hosp Morvan, Dept Microbiol, F-29609 Brest, France
[58]
Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy
[J].
Westhoff, TH
;
Jochimsen, F
;
Schmittel, A
;
Stöffler-Meilicke, M
;
Schäfer, JH
;
Zidek, W
;
Gerlich, WH
;
Thiel, E
.
BLOOD,
2003, 102 (05)
:1930-1930

Westhoff, TH
论文数: 0 引用数: 0
h-index: 0
机构:
Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany

Jochimsen, F
论文数: 0 引用数: 0
h-index: 0
机构:
Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany

Schmittel, A
论文数: 0 引用数: 0
h-index: 0
机构:
Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany

Stöffler-Meilicke, M
论文数: 0 引用数: 0
h-index: 0
机构:
Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany

Schäfer, JH
论文数: 0 引用数: 0
h-index: 0
机构:
Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany

Zidek, W
论文数: 0 引用数: 0
h-index: 0
机构:
Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany

Gerlich, WH
论文数: 0 引用数: 0
h-index: 0
机构:
Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany

Thiel, E
论文数: 0 引用数: 0
h-index: 0
机构:
Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany
[59]
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
[J].
Yeo, W
;
Chan, PKS
;
Ho, WM
;
Zee, B
;
Lam, KC
;
Lei, KIK
;
Chan, ATC
;
Mok, TSK
;
Lee, JJ
;
Leung, TWT
;
Zhong, S
;
Johnson, PJ
.
JOURNAL OF CLINICAL ONCOLOGY,
2004, 22 (05)
:927-934

Yeo, W
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Chan, PKS
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Ho, WM
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Zee, B
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Lam, KC
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Lei, KIK
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Chan, ATC
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Mok, TSK
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Lee, JJ
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Leung, TWT
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Zhong, S
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Johnson, PJ
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[60]
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
[J].
Yeo, W
;
Zee, B
;
Zhong, S
;
Chan, PKS
;
Wong, WL
;
Ho, WM
;
Lam, KC
;
Johnson, PJ
.
BRITISH JOURNAL OF CANCER,
2004, 90 (07)
:1306-1311

Yeo, W
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Zee, B
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Zhong, S
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Chan, PKS
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Wong, WL
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Ho, WM
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Lam, KC
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Johnson, PJ
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Ctr Canc, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China